The use of the tumour necrosis factor antagonist infliximab in heart transplant recipients: two case reports.
Metyas
S
S
La
D
D
Arkfeld
D G
DG
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D005260:Female; D016027:Heart Transplantation; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D011184:Postoperative Period; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab